Riskpilot← Back to searchSign inGet full accessSynphora Aktiebolag
ABIn liquidationOrg 5560722703Other research and experimental development on natural sciences and engineering · NACE 7219Est. 19600 employees
Revenue 2022
SEK 0
EBITDA margin
—
+87% vs 2021
Equity ratio
80.2%
Financial strength
Net profit 2022
SEK -201K
+87% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -201K | +87% |
| Net profit | SEK -201K | +87% |
| Total assets | SEK 227K | -48% |
| Equity | SEK 182K | -52% |
| Employees | 0 | — |
Legal name
Synphora Aktiebolag
Org number
5560722703
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
7 juni 1960
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget skall bedriva läkemedelsutveckling samt annan därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 041 | −931 | −746 | −1 531 | −201 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 041 | −931 | −746 | −1 531 | −201 |
| Net financials | −10 | — | −1 | — | — |
| Profit before tax | −2 051 | −932 | −747 | −1 531 | −201 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 051 | −932 | −747 | −1 531 | −201 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1 686 | 538 | 2 203 | 438 | 227 |
| Equity | 1 392 | 461 | 1 914 | 383 | 182 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 294 | 77 | 289 | 55 | 45 |
| Total debt | 294 | 77 | 289 | 55 | 45 |
EBITDA margin
-20100000.0%
This company
15.8%
Market median
-127215290% vs market
20182022
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20182022
Return on equity
-110.4%
This company
18.4%
Market median
-700% vs market
20182022
Net profit margin
-20100000.0%
This company
8.1%
Market median
-248148248% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LB External Signatory | External Signatory | 2020 |
IM External Signatory | External Signatory | 2020 |
BJ Liquidator | Liquidator | 2021 |
UM External Signatory | External Signatory | 2020 |
| Former (1) | ||
PF Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Synphora Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | Liquidator | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Per Fredrik Henell | Chief Executive Officer | 0 companies |
| Mats Olof Magnus Lidgard | Chairman | 0 companies |